Morris Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Morris Capital Advisors, LLC

$106 Million
Q3 2022

A detailed history of Morris Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Morris Capital Advisors, LLC holds 35,648 shares of BMY stock, worth $2.1 Million. This represents 2.39% of its overall portfolio holdings.

Number of Shares

35,648

Previous 36,106 1.27%

Holding current value

$2.1 Million

Previous $2.78 Million 8.85%

% of portfolio

2.39%

Previous 2.48%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $59 - $35,192	-458 Reduced 1.27%	35,648 $2.53 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $51,342 - $56,545	707 Added 2.0%	36,106 $2.78 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $503,398 - $603,619	8,188 Added 30.09%	35,399 $2.59 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $494,575 - $576,559	-9,222 Reduced 25.31%	27,211 $1.7 Million
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $78,696 - $92,182	-1,330 Reduced 3.52%	36,433 $2.16 Million
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $33,369 - $36,339	-539 Reduced 1.41%	37,763 $2.52 Million
Q1 2021 Apr 16, 2021	SELL	$59.34 - $66.74 $57,263 - $64,404	-965 Reduced 2.46%	38,302 $2.42 Million
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $232,692 - $263,682	-4,030 Reduced 9.31%	39,267 $2.44 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $159,310 - $176,537	-2,774 Reduced 6.02%	43,297 $2.61 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $153,715 - $179,708	-2,804 Reduced 5.74%	46,071 $2.71 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $320,531 - $465,806	6,908 Added 16.46%	48,875 $2.72 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $2.07 Million - $2.69 Million	41,967 New	41,967 $2.69 Million

Others Institutions Holding BMY

# of Institutions

2,763

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morris Capital Advisors, LLC with notifications on news.

Account

Morris Capital Advisors, LLC Bristol Myers Squibb CO Transaction History